Cut score vs Thyroid Nodule Reporting Guide

The CUT score is a new cancer risk score for thyroid nodules suitable in any clinical setting. The CUT is an acronym indicating Clinical, Ultrasonographic and Thyroid cytology aspects of a thyroid nodule. The CUT score has been created to help clinicians with thyroid nodule preoperative malignancy risk assessment. This tool is intentionally developed on easily avalaible clinical data in order to allow physicians to apply the ‘‘CUT’’ score in any clinical setting using basic US technology. In the CUT score, the sum of each clinical (C) and/or ultrasonographic (U) suspicious feature results in the C+U sum, ranging from 0 to 10. This sum along with the five-tiered score of the fine-needle aspiration results (T = 1–5) determines the final ‘‘CUT’’ score of the TN. The C+U sum of the CUT score: helps to select thyroid nodules requiring fine-needle aspiration (e.g., the thyroid nodule with the highest C+U score in a multinodular goiter) when the thyroid cytology (T) is avalaible, allows to assess the risk of malignancy of the thyroid nodule in the final CUT score. The CUT score is designated exclusively for medical use and is not intended to be directly used by the patient to take any medical decision without a doctor’s advice. It has been created by the work of endocrinologists operating in the Policlinico Gemelli’s Division of Endocrinology. It’s a medical application derived from the following published studies: Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A. Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol. 2014 Apr 10;170(5):R203-11. doi: 10.1530/EJE-13-0995. Ianni F, Campanella P, Rota CA, Prete A, Castellino L, Pontecorvi A, Corsello SM. A meta-analysis-derived proposal for a clinical, ultrasonographic, and cytological scoring system to evaluate thyroid nodules: the "CUT" score. Endocrine. 2015 Oct 30. Ianni F, Pascucci D, Paragliola RM, Rota CA, Perotti G, Fadda G, Pontecorvi A, Corsello SM. Follow-up or Surgery for Indeterminate Thyroid Nodules: Could the CUT Score Application Be a Support for Decision-Making in the Preoperative Assessment? Thyroid. 2019 Oct 23. doi: 10.1089/thy.2018.0649.

Download includes a free trial; continued use requires a 6‑ or 12‑month auto‑renewing subscription. Thyroid Nodule Reporting Guide is a clinical decision‑support guide built around ACR TI‑RADS v2017. The app delivers step‑by‑step guidance at the point of care, streamlining thyroid‑nodule categorization on US and follow‑up so you can apply standardized recommendations with clarity and consistency—whether you practice in radiology, endocrinology, or primary care. Key Features (unlocked after the free trial with an active subscription) ACR TI‑RADS v2017 Integration • Full, in‑app access to all five TI‑RADS categories (TR1–TR5), including point-based criteria for Composition, Echogenicity, Shape, Margin, and Echogenic Foci. Management recommendations are drawn directly from the ACR guidelines for immediate, confident application. Dynamic TI‑RADS Card • A single, color-coded card displays your TI-RADS score as you assess each feature—composition, echogenicity, shape, margin, and echogenic foci. The point total updates live with each selection, and once enough information is available, the card immediately reflects the final TI-RADS category. Expert Insight Guide • Tap into our comprehensive guide for expert review of guidelines nuances. Self‑Assessment Mode • Expert-curated self-assessment question packs. Enhanced Readability • Dark-mode support, dynamic text sizing, and a distraction-free interface designed for high-pressure reading environments. Offline Access • All guideline logic run on‑device—no login or server needed. Medical Disclaimer: This app is for informational purposes only and is not a substitute for professional medical advice. In addition to using this app, always consult a qualified healthcare provider for diagnosis and treatment decisions. Subscription Options ¹ • 6‑Month subscription (free trial available) | Price displayed in‑app; may vary by region • 12‑Month subscription (free trial available) | Price displayed in‑app; may vary by region We strive to incorporate any updates to ACR TI‑RADS guidance within 30 days of publication and plan to release new self‑assessment question packs semi‑annually.  Future feature additions and update frequency may change without notice. ¹ Payment & Renewal – Payment is charged to your Apple ID at confirmation. Subscriptions renew automatically unless auto‑renew is turned off at least 24 hours before the end of the current period. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions. Note: Switching plans or re‑subscribing during the free trial will forfeit any remaining trial time and incur immediate charges. Privacy Policy: https://radiologiq.squarespace.com/privacy Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/